Results 21 to 30 of about 84,866 (261)
Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study [PDF]
Mental Health ClinicianIntroduction To compare the effectiveness of droperidol and haloperidol for acute agitation in the emergency department. Methods Data from electronic health records were collected from January 1, 2022, to August 25, 2023, across 6 emergency departments ...
Francesca DiGuglielmo, PharmD +4 more
doaj +1 more source
European Psychiatry, 2021 Introduction The only FDA approval therapeutic for schizoaffective disorder is paliperidone. Hiperprolactinemia is one of the most frequent side effects induced by first generation antipsychotics (FGA) or by second generation antipsychotic (SGA), such ...
D. Rodrigues +3 more
doaj +1 more source
Focus, 2020 Physicians who treat patients with schizophrenia frequently encounter complex clinical situations not fully addressed by published treatment guidelines. Some of these situations lead to antipsychotic polypharmacy, often prescribed when clinical and social obstacles prevent access to clozapine and patients have had suboptimal responses to nonclozapine ...
Adriana, Foster, Jordanne, King
openaire +3 more sources
Antipsychotics for irritability in children with Autism Spectrum Disorders
European Psychiatry, 2022 Introduction Autism is a neurodevelopmental disorder characterized by qualitative impairments in social interaction, communication, and restricted and repetitive behaviors [1]. Despite of these symptoms, some patients present different manifestations of
V. Muñoz Martinez +2 more
doaj +1 more source
Dosage of antipsychotics in China routine practice
European Psychiatry, 2021 Introduction The antipsychotic dosage of Chinese schizophrenia patients has rarely been studied, although nonstandard dosage has impact on prognosis. Objectives To describe the dosage of antipsychotics in China routine practice.
T. Zhang, R. Chi, T. Wu, Y. Xu, W. Dong
doaj +1 more source
Tobacco dependence and schizophrenia: Tunisian cross-sectional study of 50 cases
European Psychiatry, 2022 Introduction Tobacco-use is currently one of the major public health problems and is more common among patients with schizophrenia. Objectives We aimed in this study to estimate the prevalence of smoking in a population of patients with schizophrenia ...
M. Jabeur +5 more
doaj +1 more source
Journal of Market Access & Health Policy, 2017 Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult.
Clément François +8 more
doaj +1 more source
Treatment of early onset schizophrenia: Recent trends, challenges and future considerations
Frontiers in Psychiatry, 2012 Early onset schizophrenia (onset before adulthood) is a rare, severe and chronic form of schizophrenia. Antipsychotic treatment remains the mainstay of treatment although current medications provide suboptimal response at best.
Nora S Vyas, Nitin eGogtay
doaj +1 more source
Quetiapine-induced bicytopenia. Case report and literature review
European Psychiatry, 2021 Introduction Low white blood cell counts and agranulocytosis are a relatively rare side effect of atypical antipsychotic treatment. Like most atypical antipsychotics, quetiapine only has a 1%-4% risk of low blood cell count.
T. Gutiérrez Higueras +3 more
doaj +1 more source
Frontiers in Pharmacology, 2013 Objective: Medication adherence is extremely important in preventing relapse and lowering symptoms in schizophrenic patients. However, estimates show that nearly half of these patients have poor adherence. The Brief Adherence Rating Scale (BARS) seems to
Emmanuel eStip +12 more
doaj +1 more source